Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "Phase 1b/2 CARTITUDE-1 Study Final Results - Ciltacabtagene Autoleucel in Heavily Pretreated Patients With R/R MM"

134 views
July 14, 2023
0 Comments
Login to view comments. Click here to Login
Hematology